Preetha Reddy files SEBI takeover disclosure under Regulation 31(4)
Preetha Reddy, a key promoter of Apollo Hospitals, filed a Regulation 31(4) disclosure with NSE on 5 June 2026. This regulation mandates disclosure when a person acquires or disposes of shares and PIBs, crossing prescribed thresholds (typically 1%, and thereafter in multiples of 1% or 2%). The disclosure is a cornerstone of India's takeover code, requiring transparency in shareholding changes. The specific quantum of shares acquired, resulting shareholding percentage, and consideration are contained in the full filing document.
Why it mattersThe filing triggers disclosure obligations under SEBI (SAST) Regulations 2011; the specific shareholding threshold crossed and acquisition details remain to be disclosed in the full submission, which may reveal promoter consolidation or acquisition activity.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Archives – Apollo Hospitals Enterprise Limited Disclosure · official
- Bar & Bench – Corporate Law Tracker
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026